Joseph J. Wolk - Feb 14, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Exec VP, CFO
Signature
Raavi K. Deol, as attorney-in-fact for Joseph J. Wolk
Stock symbol
JNJ
Transactions as of
Feb 14, 2022
Transactions value $
-$155,511
Form type
4
Date filed
2/15/2022, 07:04 PM
Next filing
Dec 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +3.25K +14.09% $0.00 26.3K Feb 14, 2022 Direct F1
transaction JNJ Common Stock Tax liability -$156K -921 -3.5% $168.85 25.4K Feb 14, 2022 Direct F2
holding JNJ Common Stock 1.94K Feb 14, 2022 By 401k F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -3.25K -100% $0.00* 0 Feb 14, 2022 Common Stock 3.25K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).